Lexeo Therapeutics, Inc. (LXEO) — 10-Q Filings
All 10-Q filings from Lexeo Therapeutics, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
- 10-Q Filing — May 11, 2026
-
Lexeo Narrows Q3 Loss, Boosts Cash with Private Placement
— Nov 5, 2025 Risk: high
Lexeo Therapeutics, Inc. (LXEO) reported a net loss of $20.283 million for the three months ended September 30, 2025, a 31.22% improvement from the $29.489 mill -
Lexeo Therapeutics Files Q2 2025 10-Q
— Aug 14, 2025 Risk: medium
Lexeo Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2025. The company's fiscal year ends on December 31st. Key dates mentioned include the IP -
Lexeo Therapeutics Files Q1 2025 10-Q
— May 12, 2025 Risk: medium
Lexeo Therapeutics, Inc. filed its quarterly report for the period ending March 31, 2025. The company's business address is 345 Park Avenue South, Floor 6, New -
Lexeo Therapeutics Files Q2 2024 10-Q
— Aug 12, 2024 Risk: medium
Lexeo Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its business operati -
Lexeo Therapeutics Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk:
Lexeo Therapeutics, Inc. (LXEO) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Lexeo Therapeutics, Inc. filed a 10-Q report for the period ending
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX